Skip to main content
Log in

Treatment of graves' ophthalmopathy with cyclosporin a

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

To evaluate the effect of Cyclosporin A in the management of Graves' ophthalmopathy, we treated 13 patients with severe euthyroid endocrine eye disease with the immunosuppressive drug. Follow up consisted of clinical investigation, laboratory evaluation with detailed thyroid function tests and complete ophthalmological assessments including A and B scan ultrasound and computerized tomography (CT) of the orbits. Cyclosporin A given over 4–7 months resulted in improvement of clinical signs and symptoms of the disease due to a positive effect of the drug on soft tissue changes. The more objective methods did not demonstrate any unequivocal change in proptosis, visual acuity, intraocular pressure and thickness of extraocular muscles. Cyclosporin A was not able to stop acute progression of ophthalmopathy in one patient and did not obviate surgical decompression of the orbits in two more patients. There was no measurable effect of treatment on the underlying immunological process with regard to thyroid disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CT:

computerized tomography

CyA:

Cyclosporin A

TBG:

thyroxine binding globulin

TDA:

TSH displacing activity

T3 :

triiodothyronine

T4 :

thyroxine

TSH:

thyroid stimulating hormone

References

  1. Beveridge T (1982) Cyclosporin A, 1st edn, Elsevier Biomedical Press, Amsterdam, pp 561–564

    Google Scholar 

  2. Bigos ST, Nisula BC, Daniels GH, Eastman RC, Johnston HH, Kohler PO (1979) Cyclophosphamide in the management of advanced Graves' ophthalmopathy. Ann Int Med 90:921–923

    Article  CAS  PubMed  Google Scholar 

  3. Brabant G, Peter H, Becker H, Schwarzrock R, Wonigeit K, Hesch RD (1984) Cyclosporin in infiltrative eye disease. Lancet 1:515–516

    Article  CAS  PubMed  Google Scholar 

  4. DeSanto LW, Gorman CA (1973) Selection of patients and choice of operation for orbital decompression in Graves' ophthalmopathy. Laryngoskope 83:945–952

    Article  CAS  Google Scholar 

  5. Enzmann DR, Donaldson SS, Kriss JP (1979) Appearance of Graves' disease on orbital computed tomography. J Comput Assist Tomogr 3 (6):815–819

    Article  CAS  PubMed  Google Scholar 

  6. Erhardt F, Marschner I, Pickardt CR, Scriba PC (1973) Verbesserung und Qualitätskontrolle der radioimmunologischen Thyrotropin-Bestimmung. J Clin Chem Clin Biochem 11:381–387

    CAS  Google Scholar 

  7. Howlett TA, Lawton NF, Pells P, Besser GM (1984) Deterioration of severe Graves' ophthalmopathy during cyclosporin treatment. Lancet 2:1101

    Article  CAS  PubMed  Google Scholar 

  8. Kelly W, Longson D, Smithard D, Fawcitt R, Wensley R, Noble J, Keeley J (1983) An evaluation of plasma exchange for Graves' ophthalmopathy. Clin Endocrinol 18:485–493

    Article  CAS  Google Scholar 

  9. Kirmse L, Lahrtz H-G, Schemmel K, Waschulzik G (1975) Totale Thyreoidektomie bei progredienter endokriner Orbitopathie. Dtsch Med Wochenschr 100:535–537

    Article  CAS  PubMed  Google Scholar 

  10. Markl A, Boergen KP, Hasenfratz G, Mayr B, Fink U, Lissner J (19884) Cumputerized tomography in the evaluation of endocrine ophthalmopathy. Acta Endocrinol 105 Suppl 264:84

    Google Scholar 

  11. Ossoinig KC (1984) Ultrasonic diagnosis of Graves' ophthalmopathy. In: Gorman CA et al. (eds) The eye and orbit in thyroid disease. Raven Press, New York, pp 185–211

    Google Scholar 

  12. Teng CS, Crombie AL, Hall R, Ross WM (1980) An evaluation of supervoltage orbital irradiation for Graves' ophthalmopathy. Clin Endocrinol 13:545–551

    Article  CAS  Google Scholar 

  13. Utech Ch H, Wulle KD, Kiefer H (1985) Cyclosporin A-Behandlung bei schwerer endokriner Ophthalmopathie (Leserzuchrift). Dtsch med Wochenschr 110:155–156

    CAS  PubMed  Google Scholar 

  14. Weetman AP, Ludgate M, Mills PV, McGregor AM, Beck L, Lazarus JH, Hall R (1983) Cyclosporin improves Graves' ophthalmopathy. Lancet 2:486–489

    Article  CAS  PubMed  Google Scholar 

  15. Werner SC (1977) Modification of the classification of the eye changes of Graves' disease: recommendations of the ad hoc committee of the American Thyroid Association (editorial). J Clin Endocrinol Metab 44:203–204

    Article  CAS  PubMed  Google Scholar 

  16. Witte A, Habermann J, Pickardt CR (1982) Is TSH-displacing activity a helpful parameter in diagnosis and follow-up of Graves' disease. Acta Endocrinol Suppl 246:73

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Witte, A., Landgraf, R., Markl, A. et al. Treatment of graves' ophthalmopathy with cyclosporin a. Klin Wochenschr 63, 1000–1004 (1985). https://doi.org/10.1007/BF01737636

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01737636

Key words

Navigation